Metsera announces positive results in newest Phase IIa GLP-1RA
The New York company is hoping to enter the GLP-1RA space with its newest offering requiring dosing every month over ...
ENDPOINTS NEWS10m
FDA sets an ef­fi­ca­cy thresh­old for fu­ture weight loss drugs
New an­ti-obe­si­ty drugs should meet a min­i­mum lev­el of weight loss to be con­sid­ered for ap­proval, the FDA said ...